glp 1 increase insulin secretion JCI Glucagon-like peptide-1 - Wikipedia
Description
This risk may be explained by the delay in gastric emptying caused by incretins and the associated increase in nausea
Further clinical trials are required to define the benefits and risks of taking a GLP-1 drug in the pouch population
Gilbert MP, Pratley RE
This study was supported by the CAMS Innovation Fund for Medical Sciences (No
Diabetes Care 43 , 28592869 (2020) P
